Based on variation in nucleotide sequence within restricted regions in the putative C (core) gene of hepatitis C virus (HCV), four groups of HCV have been postulated in a panel of 44 HCV isolates. They were provisionally designated types I, II, III and IV. A method for typing HCV was developed, depending on the amplification of a C gene sequence by polymerase chain reaction using a universal primer (sense) and a mixture of four type-specific primers (antisense). HCV types were determined by the size of the products specific to each of them. Type II was found in HCV samples from 131 (82%) of 159 blood donors, more often than in those from 48 (60%) of 80 patients with non-A, non-B (NANB) liver disease in Japan (P < 0.01). In 11 haemophiliacs who had received imported coagulation factor concentrates, type I was found in five, as against type II in four. Double infection with two different HCV types was found in two patients with chronic NANB liver disease (types I and II; II and III) and two haemophiliacs (types I and II; I and III). HCV types were identical in mother and baby in each of two examples of perinatal transmission, and were also identical in donor and recipient in a case of accidental needle exposure.
AlterH. J.,
PurcellR. H.,
ShihJ. W.,
MelpolderJ. C.,
HoughtonM.,
ChooQ.-L.,
KuoG.1989a; Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. New England Journal of Medicine 321:1494–1500
AlterM. J.,
ColemanP. J.,
AlexanderW. J.,
KramerE.,
MillerJ. K.,
MandelE.,
HadlerS. C.,
MargolisH. S.1989b; Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. Journal of the American Medical Association 262:1201–205
AlterM. J.,
HadlerS. C.,
JudsonF. N.,
MaresA.,
AlexanderW. J.,
HuP. Y.,
MillerJ. K.,
MoyerL. A.,
FieldsH. A.,
BradleyD. W.,
MargolisH. S.1990; Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. Journal of the American Medical Association 264:2231–2235
BruixJ.,
BarreraJ. M.,
CalvetX.,
ErcillaG.,
CostaJ.,
Sanchez-TapiasJ. M.,
VenturaM.,
VallM.,
BrugueraM.,
BruC.,
CastilloR.,
RodesJ.1989; Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet ii:1004–1006
ChooQ.-L.,
KuoG.,
WeinerA. J.,
OverbyL. R.,
BradleyD. W.,
HoughtonM.1989; Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359–362
ChooQ.-L.,
RichmanK. H.,
HanJ. H.,
BergerK.,
LeeC.,
DongC.,
GallegosC.,
CoitD.,
Medina-SelbyA.,
BarrP. J.,
WeinerA. J.,
BradleyD. W.,
KuoG.,
HoughtonM.1991; Genetic organization and diversity of the hepatitis C virus. Proceedings of the National Academy of Sciences, U.S.A 88:2451–2455
EnomotoN.,
TakadaA.,
NakaoT.,
DateT.1990; There are two major types of hepatitis C virus in Japan. Biochemical and Biophysical Research Communications 170:1021–1025
EstebanJ. I.,
EstebanR.,
ViladomiuL.,
Lopez-TalaveraJ. C.,
GonzalezA.,
HernandezJ. M.,
RogetM.,
VargasV.,
GenescaJ.,
ButiM.,
GuardiaJ.,
HoughtonM.,
ChooQ. L.,
KuoG.1989; Hepatitis C virus antibodies among risk groups in Spain. Lancet ii:294–297
FarciP.,
AlterH. J.,
WongD.,
MillerR. H.,
ShihJ. W.,
JettB.,
PurcellR. H.1991; A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. New England Journal of Medicine 325:98–104
GarsonJ. A.,
PrestonF. E.,
MakrisM.,
TukeP.,
RingC.,
MachinS. J.,
TedderR. S.1990; Detection by PCR of hepatitis C virus in factor VIII concentrates. Lancet 335:1473
HijikataM.,
KatoN.,
MoriS.,
OotsuyamaY.,
NakagawaM.,
SugimuraT.,
OhkoshiS.,
KojimaH.,
MeguroT.,
TakiM.,
TakayamaS.,
YamadaK.,
ShimotohnoK.1990; Frequent detection of hepatitis C virus US strain in Japanese hemophiliacs. Japanese Journal of Cancer Research 81:1195–1197
KatoN.,
HijikataM.,
OotsuyamaY.,
NakagawaM.,
OhkoshiS.,
SugimuraT.,
ShimotohnoK.1990; Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proceedings of the National Academy of Sciences, U.S.A 87:9524–9528
KuboY.,
TakeuchiK.,
BoonmarS.,
KatayamaT.,
ChooQ.-L.,
KuoG.,
WeinerA. J.,
BradleyD. W.,
HoughtonM.,
SaitoI.,
MiyamuraT.1989; A cDNA fragment of hepatitis C virus isolated from an implicated donor of post-transfusion non-A, non-B hepatitis in Japan. Nucleic Acids Research 17:10367–10372
KuoG.,
ChooQ.-L.,
AlterH. J.,
GitnickG. L.,
RedekerA. G.,
PurcellR. H.,
MiyamuraT.,
DienstagJ. L.,
AlterM. J.,
StevensC. E.,
TegtmeierG. E.,
BoninoF.,
ColomboM.,
LeeW.-S.,
KuoC.,
BergerK.,
ShusterJ. R.,
OverbyL. R.,
BradleyD. W.,
HoughtonM.1989; An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362–364
MiyamuraT.,
SaitoL.,
KatayamaT.,
KikuchiS.,
TatedaA.,
HoughtonM.,
ChooQ. L.,
KuoG.1990; Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: application to diagnosis and blood screening for posttransfusion hepatitis. Proceedings of the National Academy of Sciences, U.S.A 87:983–987
NorderH.,
HammasB.,
MagniusL. O.1990; Typing of hepatitis B virus genomes by a simplified polymerase chain reaction. Journal of Medical Virology 31:215–221
OgataN.,
AlterH. J.,
MillerR. H.,
PurcellR. H.1991; Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proceedings of the National Academy of Sciences, U.S.A 88:3392–3396
OkamotoH.,
OkadaS.,
SugiyamaY.,
TanakaT.,
SugaiY.,
AkahaneY.,
MachidaA.,
MishiroS.,
YoshizawaH.,
MiyakawaY.,
MayumiM.1990a; Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. Japanese Journal of Experimental Medicine 60:215–222
OkamotoH.,
OkadaS.,
SugiyamaY.,
YotsumotoS.,
TanakaT.,
YoshizawaH.,
TsudaF.,
MiyakawaY.,
MayumiM.1990b; The 5′-terminal sequence of the hepatitis C virus genome. Japanese Journal of Experimental Medicine 60:167–177
OkamotoH.,
OkadaS.,
SugiyamaY.,
KuraiK.,
IizukaH.,
MachidaA.,
MiyakawaY.,
MayumiM.1991; Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions. Journal of General Virology 72:2697–2704
ReesinkH. W.,
WongV. C. W.,
IpH. M. H.,
van der PoelC. L.,
van Exel-OehlersP. J.,
LelieP. N.1990; Mother-to-infant transmission and hepatitis C virus. Lancet 335:1216–1217
StevensC. E.,
TaylorP. E.,
PindyckJ.,
ChooQ.-L.,
BradleyD. W.,
KuoG.,
HoughtonM.1990; Epidemiology of hepatitis C virus. A preliminary study in volunteer blood donors. Journal of the American Medical Association 263:49–53
TakamizawaA.,
MoriC.,
FukeI.,
ManabeS.,
MurakamiS.,
FujitaJ.,
OnishiE.,
AndohT.,
YoshidaI.,
OkayamaH.1991; Structure and organization of the hepatitis C virus genome isolated from human carriers. Journal of Virology 65:1105–1113
TakeuchiK.,
KuboY.,
BoonmarS.,
WatanabeY.,
KatayamaT.,
ChooQ. L.,
KuoG.,
HoughtonM.,
SaitoI.,
MiyamuraT.1990; The putative nucleocapsid and envelope protein genes of hepatitis C virus determined by comparison of the nucleotide sequences of two isolates derived from an experimentally infected chimpanzee and healthy human carriers. Journal of General Virology 71:3027–3033
UlrichP. P.,
RomeoJ. M.,
LaneP. K.,
KellyL.,
DanielL. J.,
VyasG. N.1990; Detection, semiquantitation, and genetic variation in hepatitis C virus sequences amplified from the plasma of blood donors with elevated alanine aminotransferase. Journal of Clinical Investigation861609–1614